Optos introduced ultra-widefield retinal imaging to support practitioners diagnosing, analyzing, documenting and monitoring ocular pathology that may first present in the periphery, and otherwise may go undetected using traditional examination techniques and equipment.

The new 200Tx device, designed specifically for general ophthalmologists and vitreoretinal specialists offers multiple wavelength imaging, including options for color, red-free, fluorescein angiography and autofluorescence.

With simultaneous non-contact pole-to-periphery views of more than 80% or 200 degrees of the retina in a single capture, the 200Tx helps clinicians discover more evidence of disease and guide their treatment decisions.

The 200Tx is a versatile instrument which allows the practitioner to use ultra-widefield digital retinal imaging with captures such as:

The optomap Retinal Exam is the company's core product and is implemented as a screening tool for the early detection of disease or abnormalities in the posterior segment of the eye in the context of preventative medicine and eye health and wellness.

supports enhanced capabilities (eye steering and enhanced annotation tools) for medically necessary reimbursable procedures

supports ultra-high resolution, ultra-widefield angiographic retinal analysis captured via a non-contact, non-montage and simplified acquisition process

provides an ultra-widefield retinal autofluorescence image using fundus autofluorescence with a green laser

Benefits

• Ultra-widefield retinal capture even through a small pupil
• The first imaging device offering visualization of ultra-widefield autofluorescence
   RPE changes
• Red, green and blue scanning lasers
• ResMax™ for central pole resolution enhancement
• State of the Art Image Capture and Proprietary V2 Vantage Software
• Versatile, easy to use technology offers a single simplified acquisition process
• Innovative Virtual Point™ Technology providing a panoramic view of the fundus